Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philippines seals biggest COVID-19 vaccine order yet, for 40 mln Pfizer doses

06/20/2021 | 11:45am EDT

* Deliveries to begin in late September

* Philippines has secured 113 mln doses from vaccine suppliers

* Government wants to vaccinate up to 70 million Filipinos

MANILA, June 20 (Reuters) - The Philippine government has signed a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, in its biggest coronavirus vaccine deal to date.

Deliveries of the vaccine will begin in late September, Carlito Galvez, head of the government's COVID-19 vaccine procurement, said on Sunday. It "will significantly boost our national immunisation programme and will enable us to realise our goal of achieving herd immunity by year-end," he said.

The Philippines has now ordered 113 million doses from five vaccine manufacturers, including 26 million from China's Sinovac , 10 million of Russia's Sputnik V, 20 million doses from Moderna and 17 million doses from AstraZeneca.

So far, the Philippines has adminstered slightly more than 8 million doses, of which about 6 million were first doses, making slow progress towards the government's target to vaccinate up to 70 million people this year in a country of 110 million.

The Philippines earlier this month started a programme to vaccinate 35 million people working outside their homes, while continuing to inoculate priority sectors such as healthcare workers and the elderly.

Vaccine supply around the capital Manila remains limited, while COVID-19 cases in several provinces have surged, complicating efforts to ramp up the immunisation drive in a country with some of Asia's largest numbers of infections and deaths.

The Philippines also expects 44 million doses from the international COVAX vaccine sharing facility. Orders of 16 million doses of vaccines developed by Novavax and Johnson & Johnson were still under negotiation, Galvez said.

The Philippines will allow the Pfizer-BioNTech vaccine to be given to children aged 12 to 15, possibly starting later this year, he said.

To help boost the government's COVID-19 response, a team of medical experts from the Israel Ministry of Health has arrived in Manila. Israel has been a world leader in rolling out vaccines, having successfully reduced its active COVID-19 cases and gradually reopened its economy. Most of its population has received the Pfizer-BioNTech vaccine.

Galvez said the health experts will share strategies, including how to address vaccine hesitancy. (Reporting by Enrico Dela Cruz; Editing by William Mallard and Christopher Cushing)

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.87% 8342 Delayed Quote.12.92%
MODERNA, INC. -1.25% 413.15 Delayed Quote.301.12%
NOVAVAX, INC. 9.12% 243.5 Delayed Quote.100.71%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
08/04SINOVAC BIOTECH : China's Sinovac to invest $60 mln in vaccine facility in Chile
08/04SINOVAC BIOTECH : China's Sinovac to invest $60 mln in vaccine facility in Chile
08/04Thai hospital tycoon who promised Pfizer vaccine says deal now unlikely
08/03ASTRAZENECA : Chilean study shows variations in success of COVID-19 vaccines
07/27SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
07/26SINOVAC BIOTECH : Brazil says China's Sinopharm seeks COVID-19 vaccine emergency..
07/26SINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
07/24SINOVAC BIOTECH : Indonesia prepares more ICU units, waits to see if COVID curbs..
07/23SINOVAC BIOTECH : China's Sinovac evaluates vaccine plant in Chile
07/20SINOVAC BIOTECH : Receives Approval on Sabin Strain Based Inactivated Polio Vacc..
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 110 M - -
Net cash 2020 1 040 M - -
P/E ratio 2020 6,66x
Yield 2020 -
Capitalization 642 M 642 M -
EV / Sales 2019 1,86x
EV / Sales 2020 -0,78x
Nbr of Employees 1 959
Free-Float 33,1%
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors